PDB Short entry for 3B9L HEADER LIPID BINDING PROTEIN 05-NOV-07 3B9L TITLE HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZT COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERUM ALBUMIN; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN KEYWDS PROTEIN-LIGANDS COMPLEX, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISEASE KEYWDS 2 MUTATION, GLYCATION, GLYCOPROTEIN, LIPID-BINDING, METAL-BINDING, KEYWDS 3 SECRETED, LIPID BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.ZHU,F.YANG,L.CHEN,E.J.MEEHAN,M.HUANG REVDAT 4 01-NOV-23 3B9L 1 REMARK REVDAT 3 18-JUL-12 3B9L 1 HETSYN VERSN REVDAT 2 24-FEB-09 3B9L 1 VERSN REVDAT 1 27-MAY-08 3B9L 0 JRNL AUTH L.ZHU,F.YANG,L.CHEN,E.J.MEEHAN,M.HUANG JRNL TITL A NEW DRUG BINDING SUBSITE ON HUMAN SERUM ALBUMIN AND JRNL TITL 2 DRUG-DRUG INTERACTION STUDIED BY X-RAY CRYSTALLOGRAPHY JRNL REF J.STRUCT.BIOL. V. 162 40 2008 JRNL REFN ISSN 1047-8477 JRNL PMID 18258455 JRNL DOI 10.1016/J.JSB.2007.12.004 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH X.M.HE,D.C.CARTER REMARK 1 TITL ATOMIC STRUCTURE AND CHEMISTRY OF HUMAN SERUM ALBUMIN REMARK 1 REF NATURE V. 358 209 1992 REMARK 1 REFN ISSN 0028-0836 REMARK 1 PMID 1630489 REMARK 1 DOI 10.1038/358209A0 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.GHUMAN,P.A.ZUNSZAIN,I.PETITPAS,A.A.BHATTACHARYA,M.OTAGIRI, REMARK 1 AUTH 2 S.CURRY REMARK 1 TITL STRUCTURAL BASIS OF THE DRUG-BINDING SPECIFICITY OF HUMAN REMARK 1 TITL 2 SERUM ALBUMIN REMARK 1 REF J.MOL.BIOL. V. 353 38 2005 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 16169013 REMARK 1 DOI 10.1016/J.JMB.2005.07.075 REMARK 1 REFERENCE 3 REMARK 1 AUTH F.YANG,C.BIAN,L.ZHU,G.ZHAO,Z.HUANG,M.HUANG REMARK 1 TITL EFFECT OF HUMAN SERUM ALBUMIN ON DRUG METABOLISM: STRUCTURAL REMARK 1 TITL 2 EVIDENCE OF ESTERASE ACTIVITY OF HUMAN SERUM ALBUMIN REMARK 1 REF J.STRUCT.BIOL. V. 157 348 2007 REMARK 1 REFN ISSN 1047-8477 REMARK 1 PMID 17067818 REMARK 1 DOI 10.1016/J.JSB.2006.08.015 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.44 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1577373.750 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.5 REMARK 3 NUMBER OF REFLECTIONS : 18107 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1421 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 51.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1621 REMARK 3 BIN R VALUE (WORKING SET) : 0.4270 REMARK 3 BIN FREE R VALUE : 0.4410 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 143 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.037 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4630 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 150 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 69.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.99000 REMARK 3 B22 (A**2) : -4.68000 REMARK 3 B33 (A**2) : -4.31000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 8.68000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM SIGMAA (A) : 0.45 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.47 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.53 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.850 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 6.130 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 8.660 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 9.150 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 12.380; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 49.81 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : MY.PARAM REMARK 3 PARAMETER FILE 3 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3B9L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1000045250. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18129 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.5 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.76 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1E7G REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 32%(W/V) POLYETHYLENE GLYCOL 3350, REMARK 280 50MM POTASSIUM PHOSPHATE, PH 7.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 91.95000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.34800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 91.95000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.34800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ALA A 2 REMARK 465 LEU A 585 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 30 -75.91 -96.17 REMARK 500 LEU A 31 59.22 -65.90 REMARK 500 GLU A 57 17.82 -57.34 REMARK 500 ASN A 61 -6.43 64.81 REMARK 500 GLU A 95 -80.65 13.22 REMARK 500 ASN A 109 65.98 -119.25 REMARK 500 ASN A 111 68.43 -65.28 REMARK 500 ASN A 130 89.71 -151.14 REMARK 500 LYS A 205 -90.15 -58.46 REMARK 500 ASP A 269 23.89 -66.70 REMARK 500 ILE A 271 -52.62 -124.60 REMARK 500 GLU A 277 -71.52 -52.68 REMARK 500 LEU A 283 -79.75 -15.14 REMARK 500 LEU A 284 -70.56 -26.44 REMARK 500 ASP A 301 -84.16 -49.79 REMARK 500 LEU A 302 113.31 29.66 REMARK 500 PRO A 303 -120.00 -59.83 REMARK 500 VAL A 310 -66.51 -131.88 REMARK 500 SER A 312 127.22 -25.32 REMARK 500 ASP A 314 -11.19 77.29 REMARK 500 ALA A 322 70.87 -157.01 REMARK 500 HIS A 367 -20.96 -39.73 REMARK 500 ALA A 371 5.11 -65.65 REMARK 500 GLU A 396 -60.54 -97.49 REMARK 500 SER A 419 123.35 -31.09 REMARK 500 CYS A 438 -10.40 -49.00 REMARK 500 GLU A 442 17.30 -52.12 REMARK 500 PRO A 468 150.39 -42.88 REMARK 500 VAL A 469 -71.73 -155.30 REMARK 500 PRO A 499 125.17 -36.49 REMARK 500 ASN A 503 103.40 -174.92 REMARK 500 LYS A 519 -24.67 -39.73 REMARK 500 ILE A 523 -6.49 -53.10 REMARK 500 ALA A 546 -60.19 -92.25 REMARK 500 LYS A 564 -58.00 -142.13 REMARK 500 ALA A 569 -35.35 165.55 REMARK 500 LYS A 573 -36.19 66.13 REMARK 500 GLN A 580 7.12 -60.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR A 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR A 1005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR A 1006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR A 1007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZZ A 1009 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZZ A 1010 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3B9M RELATED DB: PDB DBREF 3B9L A 1 585 UNP P02768 ALBU_HUMAN 25 609 SEQRES 1 A 585 ASP ALA HIS LYS SER GLU VAL ALA HIS ARG PHE LYS ASP SEQRES 2 A 585 LEU GLY GLU GLU ASN PHE LYS ALA LEU VAL LEU ILE ALA SEQRES 3 A 585 PHE ALA GLN TYR LEU GLN GLN CYS PRO PHE GLU ASP HIS SEQRES 4 A 585 VAL LYS LEU VAL ASN GLU VAL THR GLU PHE ALA LYS THR SEQRES 5 A 585 CYS VAL ALA ASP GLU SER ALA GLU ASN CYS ASP LYS SER SEQRES 6 A 585 LEU HIS THR LEU PHE GLY ASP LYS LEU CYS THR VAL ALA SEQRES 7 A 585 THR LEU ARG GLU THR TYR GLY GLU MET ALA ASP CYS CYS SEQRES 8 A 585 ALA LYS GLN GLU PRO GLU ARG ASN GLU CYS PHE LEU GLN SEQRES 9 A 585 HIS LYS ASP ASP ASN PRO ASN LEU PRO ARG LEU VAL ARG SEQRES 10 A 585 PRO GLU VAL ASP VAL MET CYS THR ALA PHE HIS ASP ASN SEQRES 11 A 585 GLU GLU THR PHE LEU LYS LYS TYR LEU TYR GLU ILE ALA SEQRES 12 A 585 ARG ARG HIS PRO TYR PHE TYR ALA PRO GLU LEU LEU PHE SEQRES 13 A 585 PHE ALA LYS ARG TYR LYS ALA ALA PHE THR GLU CYS CYS SEQRES 14 A 585 GLN ALA ALA ASP LYS ALA ALA CYS LEU LEU PRO LYS LEU SEQRES 15 A 585 ASP GLU LEU ARG ASP GLU GLY LYS ALA SER SER ALA LYS SEQRES 16 A 585 GLN ARG LEU LYS CYS ALA SER LEU GLN LYS PHE GLY GLU SEQRES 17 A 585 ARG ALA PHE LYS ALA TRP ALA VAL ALA ARG LEU SER GLN SEQRES 18 A 585 ARG PHE PRO LYS ALA GLU PHE ALA GLU VAL SER LYS LEU SEQRES 19 A 585 VAL THR ASP LEU THR LYS VAL HIS THR GLU CYS CYS HIS SEQRES 20 A 585 GLY ASP LEU LEU GLU CYS ALA ASP ASP ARG ALA ASP LEU SEQRES 21 A 585 ALA LYS TYR ILE CYS GLU ASN GLN ASP SER ILE SER SER SEQRES 22 A 585 LYS LEU LYS GLU CYS CYS GLU LYS PRO LEU LEU GLU LYS SEQRES 23 A 585 SER HIS CYS ILE ALA GLU VAL GLU ASN ASP GLU MET PRO SEQRES 24 A 585 ALA ASP LEU PRO SER LEU ALA ALA ASP PHE VAL GLU SER SEQRES 25 A 585 LYS ASP VAL CYS LYS ASN TYR ALA GLU ALA LYS ASP VAL SEQRES 26 A 585 PHE LEU GLY MET PHE LEU TYR GLU TYR ALA ARG ARG HIS SEQRES 27 A 585 PRO ASP TYR SER VAL VAL LEU LEU LEU ARG LEU ALA LYS SEQRES 28 A 585 THR TYR GLU THR THR LEU GLU LYS CYS CYS ALA ALA ALA SEQRES 29 A 585 ASP PRO HIS GLU CYS TYR ALA LYS VAL PHE ASP GLU PHE SEQRES 30 A 585 LYS PRO LEU VAL GLU GLU PRO GLN ASN LEU ILE LYS GLN SEQRES 31 A 585 ASN CYS GLU LEU PHE GLU GLN LEU GLY GLU TYR LYS PHE SEQRES 32 A 585 GLN ASN ALA LEU LEU VAL ARG TYR THR LYS LYS VAL PRO SEQRES 33 A 585 GLN VAL SER THR PRO THR LEU VAL GLU VAL SER ARG ASN SEQRES 34 A 585 LEU GLY LYS VAL GLY SER LYS CYS CYS LYS HIS PRO GLU SEQRES 35 A 585 ALA LYS ARG MET PRO CYS ALA GLU ASP TYR LEU SER VAL SEQRES 36 A 585 VAL LEU ASN GLN LEU CYS VAL LEU HIS GLU LYS THR PRO SEQRES 37 A 585 VAL SER ASP ARG VAL THR LYS CYS CYS THR GLU SER LEU SEQRES 38 A 585 VAL ASN ARG ARG PRO CYS PHE SER ALA LEU GLU VAL ASP SEQRES 39 A 585 GLU THR TYR VAL PRO LYS GLU PHE ASN ALA GLU THR PHE SEQRES 40 A 585 THR PHE HIS ALA ASP ILE CYS THR LEU SER GLU LYS GLU SEQRES 41 A 585 ARG GLN ILE LYS LYS GLN THR ALA LEU VAL GLU LEU VAL SEQRES 42 A 585 LYS HIS LYS PRO LYS ALA THR LYS GLU GLN LEU LYS ALA SEQRES 43 A 585 VAL MET ASP ASP PHE ALA ALA PHE VAL GLU LYS CYS CYS SEQRES 44 A 585 LYS ALA ASP ASP LYS GLU THR CYS PHE ALA GLU GLU GLY SEQRES 45 A 585 LYS LYS LEU VAL ALA ALA SER GLN ALA ALA LEU GLY LEU HET MYR A1001 16 HET MYR A1002 16 HET MYR A1003 16 HET MYR A1004 16 HET MYR A1005 16 HET MYR A1006 16 HET MYR A1007 16 HET AZZ A1009 19 HET AZZ A1010 19 HETNAM MYR MYRISTIC ACID HETNAM AZZ 3'-AZIDO-3'-DEOXYTHYMIDINE HETSYN AZZ AZIDOTHYMIDINE; ZIDOVUDINE FORMUL 2 MYR 7(C14 H28 O2) FORMUL 9 AZZ 2(C10 H13 N5 O4) HELIX 1 1 SER A 5 GLY A 15 1 11 HELIX 2 2 GLY A 15 LEU A 31 1 17 HELIX 3 3 PRO A 35 ASP A 56 1 22 HELIX 4 4 SER A 65 CYS A 75 1 11 HELIX 5 5 THR A 79 TYR A 84 1 6 HELIX 6 6 GLY A 85 LYS A 93 5 9 HELIX 7 7 GLU A 95 LYS A 106 1 12 HELIX 8 8 GLU A 119 ASN A 130 1 12 HELIX 9 9 ASN A 130 HIS A 146 1 17 HELIX 10 10 TYR A 150 CYS A 169 1 20 HELIX 11 11 ASP A 173 LEU A 203 1 31 HELIX 12 12 PHE A 206 PHE A 223 1 18 HELIX 13 13 GLU A 227 CYS A 246 1 20 HELIX 14 14 ASP A 249 GLU A 266 1 18 HELIX 15 15 ASN A 267 ILE A 271 5 5 HELIX 16 16 LEU A 275 LYS A 281 1 7 HELIX 17 17 PRO A 282 GLU A 292 1 11 HELIX 18 18 SER A 304 VAL A 310 1 7 HELIX 19 19 ASP A 314 ALA A 322 1 9 HELIX 20 20 ALA A 322 HIS A 338 1 17 HELIX 21 21 SER A 342 CYS A 361 1 20 HELIX 22 22 ASP A 365 TYR A 370 1 6 HELIX 23 23 LYS A 372 LEU A 398 1 27 HELIX 24 24 GLY A 399 LYS A 413 1 15 HELIX 25 25 SER A 419 LYS A 439 1 21 HELIX 26 26 LYS A 444 THR A 467 1 24 HELIX 27 27 SER A 470 THR A 478 1 9 HELIX 28 28 ASN A 483 ALA A 490 1 8 HELIX 29 29 HIS A 510 CYS A 514 5 5 HELIX 30 30 SER A 517 LYS A 536 1 20 HELIX 31 31 THR A 540 CYS A 559 1 20 HELIX 32 32 THR A 566 GLU A 571 1 6 HELIX 33 33 LYS A 573 ALA A 578 1 6 SSBOND 1 CYS A 53 CYS A 62 1555 1555 2.03 SSBOND 2 CYS A 75 CYS A 91 1555 1555 2.03 SSBOND 3 CYS A 90 CYS A 101 1555 1555 2.03 SSBOND 4 CYS A 124 CYS A 169 1555 1555 2.03 SSBOND 5 CYS A 168 CYS A 177 1555 1555 2.04 SSBOND 6 CYS A 200 CYS A 246 1555 1555 2.03 SSBOND 7 CYS A 245 CYS A 253 1555 1555 2.04 SSBOND 8 CYS A 265 CYS A 279 1555 1555 2.03 SSBOND 9 CYS A 278 CYS A 289 1555 1555 2.03 SSBOND 10 CYS A 316 CYS A 361 1555 1555 2.04 SSBOND 11 CYS A 360 CYS A 369 1555 1555 2.03 SSBOND 12 CYS A 392 CYS A 438 1555 1555 2.03 SSBOND 13 CYS A 437 CYS A 448 1555 1555 2.04 SSBOND 14 CYS A 461 CYS A 477 1555 1555 2.03 SSBOND 15 CYS A 476 CYS A 487 1555 1555 2.04 SSBOND 16 CYS A 514 CYS A 559 1555 1555 2.04 SSBOND 17 CYS A 558 CYS A 567 1555 1555 2.03 SITE 1 AC1 7 ARG A 117 MET A 123 TYR A 138 LEU A 139 SITE 2 AC1 7 LEU A 154 ALA A 158 ARG A 186 SITE 1 AC2 6 LEU A 66 TYR A 150 LEU A 251 ALA A 254 SITE 2 AC2 6 ARG A 257 SER A 287 SITE 1 AC3 11 SER A 342 LEU A 345 ARG A 348 PRO A 384 SITE 2 AC3 11 ILE A 388 PHE A 403 LEU A 407 LEU A 430 SITE 3 AC3 11 GLY A 431 LEU A 453 ARG A 485 SITE 1 AC4 7 LEU A 387 ASN A 391 TYR A 411 LEU A 423 SITE 2 AC4 7 LEU A 460 PHE A 488 SER A 489 SITE 1 AC5 6 TYR A 401 PHE A 507 LYS A 525 LEU A 532 SITE 2 AC5 6 MET A 548 GLN A 580 SITE 1 AC6 4 ALA A 213 SER A 232 ASP A 324 GLY A 328 SITE 1 AC7 12 LYS A 199 TRP A 214 ARG A 218 ARG A 222 SITE 2 AC7 12 LEU A 238 HIS A 242 ARG A 257 LEU A 260 SITE 3 AC7 12 ALA A 261 ILE A 264 SER A 287 ILE A 290 SITE 1 AC8 6 TYR A 150 GLU A 153 SER A 192 GLN A 196 SITE 2 AC8 6 HIS A 242 ARG A 257 SITE 1 AC9 8 LEU A 115 ILE A 142 HIS A 146 PHE A 149 SITE 2 AC9 8 TYR A 161 ARG A 186 GLY A 189 LYS A 190 CRYST1 183.900 38.696 95.867 90.00 104.35 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005438 0.000000 0.001391 0.00000 SCALE2 0.000000 0.025842 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010767 0.00000